David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Columbus McKinnon
CMCO
$519M
| $2.54M | ﹤0.01% |
166,436
+28,822
| +21% | +$440K |
|
2452
iShares MSCI South Africa ETF
EZA
$595M
| $2.54M | ﹤0.01% |
+47,279
| New | +$2.37M |
|
|
JBGS
2453
JBG SMITH
JBGS
$723M
| $2.53M | ﹤0.01% |
146,297
+72,214
| +97% | +$1.18M |
|
2454
Workiva
WK
$4.05B
| $2.53M | ﹤0.01% |
+36,968
| New | +$2.54M |
|
2455
Resideo Technologies
REZI
$3.02B
| $2.52M | ﹤0.01% |
114,454
-139,296
| -55% | -$2.66M |
|
2456
PUT
BWX Technologies
BWXT
$14B
| $2.52M | ﹤0.01% |
+17,500
| New | +$2.04M |
|
|
TACH
2457
Titan Acquisition Corp
TACH
$362M
| $2.52M | ﹤0.01% |
+250,002
| New | +$2.51M |
|
2458
Live Nation Entertainment
LYV
$42.5B
| $2.52M | ﹤0.01% |
16,645
-163,410
| -91% | -$22.5M |
|
2459
PUT
XPeng
XPEV
$11.2B
| $2.51M | ﹤0.01% |
140,500
-220,200
| -61% | -$4.3M |
|
2460
Brookdale Senior Living
BKD
$2.91B
| $2.51M | ﹤0.01% |
360,449
-413,011
| -53% | -$2.69M |
|
2461
Guidewire Software
GWRE
$15.9B
| $2.51M | ﹤0.01% |
10,647
-1,789
| -14% | -$384K |
|
2462
CALL
ScottsMiracle-Gro
SMG
$3.57B
| $2.51M | ﹤0.01% |
38,000
+20,800
| +121% | +$1.2M |
|
2463
iShares Russell Mid-Cap Growth ETF
IWP
$20.5B
| $2.5M | ﹤0.01% |
18,050
-8,274
| -31% | -$1.05M |
|
2464
CALL
GigaCloud Technology
GCT
$1.86B
| $2.49M | ﹤0.01% |
126,100
+37,300
| +42% | +$596K |
|
2465
AnaptysBio
ANAB
$1.72B
| $2.49M | ﹤0.01% |
112,349
-17,305
| -13% | -$362K |
|
2466
BioLife Solutions
BLFS
$1.81B
| $2.49M | ﹤0.01% |
+115,712
| New | +$2.61M |
|
2467
PUT
Archer Daniels Midland
ADM
$38.6B
| $2.49M | ﹤0.01% |
47,200
-11,600
| -20% | -$564K |
|
2468
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.07B
| $2.49M | ﹤0.01% |
11,794
+7,561
| +179% | +$1.37M |
|
2469
PUT
Repligen
RGEN
$10.2B
| $2.49M | ﹤0.01% |
20,000
| – | – |
|
2470
CALL
Wheaton Precious Metals
WPM
$70.9B
| $2.49M | ﹤0.01% |
27,700
| – | – |
|
2471
Franklin Covey
FC
$227M
| $2.48M | ﹤0.01% |
108,591
+53,425
| +97% | +$1.18M |
|
2472
PUT
Teva Pharmaceuticals
TEVA
$44.2B
| $2.47M | ﹤0.01% |
147,500
+49,200
| +50% | +$794K |
|
|
BXBL
2473
BOXABL Inc
BXBL
$1.54B
| $2.47M | ﹤0.01% |
250,000
| – | – |
|
2474
CALL
Stanley Black & Decker
SWK
$15.1B
| $2.47M | ﹤0.01% |
36,400
-41,800
| -53% | -$2.7M |
|
2475
Magnolia Oil & Gas
MGY
$6.26B
| $2.47M | ﹤0.01% |
109,679
-195,581
| -64% | -$4.33M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.